Sboner, Andrea

Publications

Sort by

Co-Author Network

selected publications

The Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023 Academic Article GET IT
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Blood advances. 2023 Academic Article GET IT
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023 Academic Article GET IT
Times cited: 5
The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer. Cancer research. 2023 Academic Article GET IT
Times cited: 3
Whole-genome characterization of myoepithelial carcinomas of the soft tissue. Cold Spring Harbor molecular case studies. 2022 Academic Article GET IT
African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent. Cancer discovery. 2022 Academic Article GET IT
Times cited: 7
GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions. The American journal of surgical pathology. 2022 Academic Article GET IT
Times cited: 1
Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR). Molecular carcinogenesis. 2022 Academic Article GET IT
Times cited: 2
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science (New York, N.Y.). 2022 Academic Article GET IT
Times cited: 22
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer. The Journal of experimental medicine. 2022 Academic Article GET IT
Times cited: 3
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. Molecular oncology. 2022 Academic Article GET IT
Times cited: 4
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies. The Journal of pathology. 2022 Academic Article GET IT
Times cited: 8
Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors. Neuro-oncology advances. 2022 Academic Article GET IT
Times cited: 100
Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology. The Journal of molecular diagnostics : JMD. 2022 Review GET IT
Times cited: 5
Application of artificial intelligence to overcome clinical information overload in urological cancer. BJU international. 2022 Review GET IT
Times cited: 2
Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130. Oncogene. 2022 Academic Article GET IT
Times cited: 3
Are we there yet? A machine learning architecture to predict organotropic metastases. BMC medical genomics. 2021 Academic Article GET IT
G3BP1 inhibits Cul3^SPOP to amplify AR signaling and promote prostate cancer. Nature communications. 2021 Academic Article GET IT
Times cited: 6
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer. Nature communications. 2021 Academic Article GET IT
Times cited: 6
Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity. Cell reports. 2021 Academic Article GET IT
Times cited: 9
Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2021 Academic Article GET IT
Times cited: 2
Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors. NPJ genomic medicine. 2021 Academic Article GET IT
Times cited: 52892
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing. The oncologist. 2021 Academic Article GET IT
Times cited: 6
MicroRNA-1205 Regulation of FRYL in Prostate Cancer. Frontiers in cell and developmental biology. 2021 Academic Article GET IT
Times cited: 185
Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage. Communications biology. 2021 Academic Article GET IT
Times cited: 3
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer. Nature communications. 2021 Academic Article GET IT
Times cited: 21
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia. NPJ precision oncology. 2021 Academic Article GET IT
Times cited: 224
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer. The Journal of clinical investigation. 2021 Academic Article GET IT
Times cited: 11
Social and Clinical Determinants of COVID-19 Outcomes: Modeling Real-World Data from a Pandemic Epicenter. medRxiv : the preprint server for health sciences. 2021 Article GET IT
A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion. Journal of magnetic resonance imaging : JMRI. 2021 Academic Article GET IT
Times cited: 21
Patient-derived xenografts and organoids model therapy response in prostate cancer. Nature communications. 2021 Academic Article GET IT
Times cited: 47
Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer. 2021 GET IT
Times cited: 4
Common germline-somatic variant interactions in advanced urothelial cancer. Nature communications. 2020 Academic Article GET IT
Times cited: 13
Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome. Archives of pathology & laboratory medicine. 2020 Academic Article GET IT
Times cited: 4
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology. Translational oncology. 2020 Academic Article GET IT
Times cited: 11
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes. European urology open science. 2020 Academic Article GET IT
Times cited: 6
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity. Nature communications. 2020 Academic Article GET IT
Times cited: 49
Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples. Thyroid : official journal of the American Thyroid Association. 2020 Academic Article GET IT
Times cited: 12
Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs. Cell. 2020 Academic Article GET IT
Times cited: 80
Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2020 Article GET IT
Building an international consortium for tracking coronavirus health status. Nature medicine. 2020 Academic Article GET IT
Times cited: 18
Publisher Correction: Building an international consortium for tracking coronavirus health status. Nature medicine. 2020 Academic Article GET IT
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis. Cells. 2020 Academic Article GET IT
Times cited: 21
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma. Acta neuropathologica communications. 2020 Academic Article GET IT
Times cited: 9
Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations. Cancers. 2020 Academic Article GET IT
Times cited: 265
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA. Bioinformatics (Oxford, England). 2020 Academic Article GET IT
Times cited: 5
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes. Nature communications. 2020 Academic Article GET IT
Times cited: 20
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. The Journal of clinical investigation. 2020 Academic Article GET IT
Times cited: 88
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy. Molecular cancer therapeutics. 2020 Academic Article GET IT
Times cited: 32
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 36
Clinical features of neuroendocrine prostate cancer. European journal of cancer (Oxford, England : 1990). 2019 Academic Article GET IT
Times cited: 138
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 35
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 105
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer. The Journal of clinical investigation. 2019 Academic Article GET IT
Times cited: 84
Publisher Correction: The long tail of oncogenic drivers in prostate cancer. Nature genetics. 2019 Article GET IT
Times cited: 5
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019 Academic Article GET IT
Times cited: 107
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis. Cancer cell. 2019 Article GET IT
Times cited: 17
Genomic correlates of clinical outcome in advanced prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 2019 Academic Article GET IT
Times cited: 561
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis. Cancer cell. 2019 Academic Article GET IT
Times cited: 46
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer. Science translational medicine. 2019 Academic Article GET IT
Times cited: 83
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer. 2019 GET IT
Times cited: 4
Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma. 2019 GET IT
Times cited: 5
The application of precision medicine in diagnosing familial Mediterranean fever. Leukemia & lymphoma. 2019 Letter GET IT
Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2018 Academic Article GET IT
Times cited: 6
Publisher Correction: Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018 Academic Article GET IT
Times cited: 2
ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Molecular cell. 2018 Academic Article GET IT
Times cited: 48
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 130
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma. The Journal of pathology. 2018 Academic Article GET IT
Times cited: 28
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer. JCO precision oncology. 2018 Academic Article GET IT
Times cited: 29
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018 Academic Article GET IT
Times cited: 353
BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy. JCO precision oncology. 2018 Academic Article GET IT
Times cited: 2
Patient derived organoids to model rare prostate cancer phenotypes. Nature communications. 2018 Academic Article GET IT
Times cited: 203
The long tail of oncogenic drivers in prostate cancer. Nature genetics. 2018 Academic Article GET IT
Times cited: 458
Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer. Cell reports. 2018 Academic Article GET IT
Times cited: 27
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine. Cancer. 2017 Academic Article GET IT
Times cited: 33
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. The Journal of clinical investigation. 2017 Academic Article GET IT
Times cited: 22
Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer cell. 2017 Academic Article GET IT
Times cited: 45
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 60
Molecular alterations in prostate cancer and association with MRI features. Prostate cancer and prostatic diseases. 2017 Academic Article GET IT
Times cited: 13
Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network. Genome biology. 2017 Academic Article GET IT
Times cited: 23
Inherited determinants of early recurrent somatic mutations in prostate cancer. Nature communications. 2017 Academic Article GET IT
Times cited: 22
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models. JCO precision oncology. 2017 Academic Article GET IT
Times cited: 584
Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations. Genome biology. 2017 Academic Article GET IT
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations. Journal of the American Medical Informatics Association : JAMIA. 2017 Academic Article GET IT
Times cited: 72
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer discovery. 2017 Academic Article GET IT
Times cited: 589
SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. Cancer cell. 2017 Academic Article GET IT
Times cited: 130
Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nature genetics. 2016 Academic Article GET IT
Times cited: 201
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer. Cancer cell. 2016 Academic Article GET IT
Times cited: 327
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care. NPJ genomic medicine. 2016 Academic Article GET IT
Times cited: 58
The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein. Oncotarget. 2016 Academic Article GET IT
Times cited: 15
PO-43 - Differential coagulation factor expression in neuroendocrine prostate cancer (PC), metastatic castrate-resistant PC, and localized prostatic adenocarcinoma. Thrombosis research. 2016 Academic Article GET IT
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer. JAMA oncology. 2016 Academic Article GET IT
Times cited: 42
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nature medicine. 2016 Academic Article GET IT
Times cited: 933
The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Academic Article GET IT
Times cited: 1945
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer. Nature. 2015 Academic Article GET IT
Times cited: 162
SPOP mutation leads to genomic instability in prostate cancer. eLife. 2015 Academic Article GET IT
Times cited: 129
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. JAMA oncology. 2015 Academic Article GET IT
Times cited: 216
A primer on precision medicine informatics. Briefings in bioinformatics. 2015 Review GET IT
Times cited: 31
Integrative clinical genomics of advanced prostate cancer. Cell. 2015 Academic Article GET IT
Times cited: 2094
MAGI3-AKT3 fusion in breast cancer amended. Nature. 2015 Letter GET IT
Times cited: 18
ASEQ: fast allele-specific studies from next-generation sequencing data. BMC medical genomics. 2015 Academic Article GET IT
Times cited: 42
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nature communications. 2014 Academic Article GET IT
Times cited: 494
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nature genetics. 2014 Academic Article GET IT
Times cited: 386
Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014 Academic Article GET IT
Times cited: 983
Unraveling the clonal hierarchy of somatic genomic aberrations. Genome biology. 2014 Academic Article GET IT
Times cited: 76
MTSS1 is a metastasis driver in a subset of human melanomas. Nature communications. 2014 Academic Article GET IT
Times cited: 53
SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia (New York, N.Y.). 2014 Academic Article GET IT
Times cited: 114
Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 129
Assessment of transcript reconstruction methods for RNA-seq. Nature methods. 2013 Academic Article GET IT
Times cited: 470
Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing. Neoplasia (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 37
Integrative annotation of variants from 1092 humans: application to cancer genomics. Science (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 279
Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456. The Journal of pathology. 2013 Letter GET IT
Times cited: 1
Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 114
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 370
Punctuated evolution of prostate cancer genomes. Cell. 2013 Academic Article GET IT
Times cited: 906
Epigenomic alterations in localized and advanced prostate cancer. Neoplasia (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 61
Identifying an ERG-positive subclass with clinical progression using expression profiling. European urology. 2013 Editorial Article GET IT
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 162
An integrated encyclopedia of DNA elements in the human genome. Nature. 2012 Academic Article GET IT
Times cited: 11446
VAT: a computational framework to functionally annotate variants in personal genomes within a cloud-computing environment. Bioinformatics (Oxford, England). 2012 Academic Article GET IT
Times cited: 51
Genomic analysis of the hydrocarbon-producing, cellulolytic, endophytic fungus Ascocoryne sarcoides. PLoS genetics. 2012 Academic Article GET IT
Times cited: 63
IQSeq: integrated isoform quantification analysis based on next-generation sequencing. PloS one. 2012 Academic Article GET IT
Times cited: 5
Genomics and privacy: implications of the new reality of closed data for the field. PLoS computational biology. 2011 Review GET IT
Times cited: 60
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer discovery. 2011 Academic Article GET IT
Times cited: 633
Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Science translational medicine. 2011 Academic Article GET IT
Times cited: 272
The real cost of sequencing: higher than you think!. Genome biology. 2011 Academic Article GET IT
Times cited: 268
A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS biology. 2011 Academic Article GET IT
Times cited: 902
Diverse protein kinase interactions identified by protein microarrays reveal novel connections between cellular processes. Genes & development. 2011 Academic Article GET IT
Times cited: 54
The genomic complexity of primary human prostate cancer. Nature. 2011 Academic Article GET IT
Times cited: 990
Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science (New York, N.Y.). 2010 Academic Article GET IT
Times cited: 733
RSEQtools: a modular framework to analyze RNA-Seq data using compact, anonymized data summaries. Bioinformatics (Oxford, England). 2010 Academic Article GET IT
Times cited: 81
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome research. 2010 Academic Article GET IT
Times cited: 157
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome biology. 2010 Academic Article GET IT
Times cited: 128
Comparison and calibration of transcriptome data from RNA-Seq and tiling arrays. BMC genomics. 2010 Academic Article GET IT
Times cited: 88
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC medical genomics. 2010 Academic Article GET IT
Times cited: 186
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. Nucleic acids research. 2010 Academic Article GET IT
Times cited: 19
Robust-linear-model normalization to reduce technical variability in functional protein microarrays. Journal of proteome research. 2009 Academic Article GET IT
Times cited: 55
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Neoplasia (New York, N.Y.). 2009 Academic Article GET IT
Times cited: 103
Distinct genomic aberrations associated with ERG rearranged prostate cancer. Genes, chromosomes & cancer. 2009 Academic Article GET IT
Times cited: 83
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. International journal of cancer. 2008 Academic Article GET IT
Times cited: 35
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. Journal of the National Cancer Institute. 2008 Academic Article GET IT
Times cited: 264
The role of disorder in interaction networks: a structural analysis. Molecular systems biology. 2008 Academic Article GET IT
Times cited: 181
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. Cancer research. 2007 Academic Article GET IT
Times cited: 61
UbcH10 is overexpressed in malignant breast carcinomas. European journal of cancer (Oxford, England : 1990). 2007 Academic Article GET IT
Times cited: 68
Comparing classical pathways and modern networks: towards the development of an edge ontology. Trends in biochemical sciences. 2007 Academic Article GET IT
Times cited: 48
UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene. 2006 Academic Article GET IT
Times cited: 69
TMABoost: an integrated system for comprehensive management of tissue microarray data. IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society. 2006 Academic Article GET IT
Times cited: 21
An automated procedure to properly handle digital images in large scale tissue microarray experiments. Computer methods and programs in biomedicine. 2005 Academic Article GET IT
Times cited: 16
Modeling clinical judgment and implicit guideline compliance in the diagnosis of melanomas using machine learning. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2005 Academic Article GET IT
Times cited: 16
Clinical validation of an automated system for supporting the early diagnosis of melanoma. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI). 2004 Academic Article GET IT
Times cited: 18
[Tissue microarrays in oncology]. Pathologica. 2003 Academic Article GET IT
Times cited: 2
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. Medical informatics and the Internet in medicine. 2003 Academic Article GET IT
Times cited: 19
A multiple classifier system for early melanoma diagnosis. Artificial intelligence in medicine. 2003 Academic Article GET IT
Times cited: 102
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. Journal of telemedicine and telecare. 2002 Academic Article GET IT
Times cited: 9
Design and initial implementation of a regional tele-oncology project. Journal of telemedicine and telecare. 2000 Academic Article GET IT
Times cited: 10

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response awarded by National Cancer Institute Co-Investigator 2021 - 2026
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers awarded by National Cancer Institute Co-Investigator 2021 - 2026
Clonal Hematopoiesis as a determinant for bone marrow toxicities for targeted radiation therapies in prostate cancer. awarded by United States Department of Defense Co-Investigator 2022 - 2025
Collaborative genomic alterations and transcriptional control in prostate cancer awarded by National Cancer Institute Co-Investigator 2019 - 2024
Unraveling the landscape of homologous recombination deficiency in patients with breast and prostate cancer across the African diaspora in NYC awarded by National Human Genome Research Institute Co-Investigator 2020 - 2023
Research collaboration agreement w/ Eli Lilly and Company awarded by Eli Lilly and Company Co-Investigator 2019 - 2023
G3BP1 Suppresses SPOP Ubiquitin Ligase to Promote Prostate Tumorigenesis awarded by National Cancer Institute Co-Investigator 2018 - 2023
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer awarded by National Cancer Institute Co-Investigator 2017 - 2023

Personalized in vitro models to advance precision medicine awarded by National Cancer Institute Key Personnel 2019 - 2023
Improving the Diagnosis of Congenital Genitourinary Birth Defects awarded by National Institute of Diabetes & Digestive & Kidney Diseases Key Personnel 2018 - 2023

more ...

less ...

Background

education and training

Ph.D., University of Trento (Italy) 2005
M.S., University of Trento (Italy) 1998

Contact

full name

Andrea Sboner

primary email

ans2077@med.cornell.edu

VIVO Weill Cornell Medical College

Andrea Sboner Associate Professor of Pathology and Laboratory Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email